GENSAIC
House mark for pharmaceutical preparations for human use, namely, pharmaceuticals for the treatment of cancer, metabolic diseases, cardiovascular diseases, neurological diseases, age-related diseases, immunological diseases, and genetic diseases, pharmaceuticals for the treatment of diseases and disorders with genetic etiology, gene therapies, and nucleic acid therapies; House mark for pharmaceutical preparations for veterinary use, namely, pharmaceuticals for the treatment of cancer and age-...
Pending · May 24, 2022 · 97425330 ·